Literature DB >> 189285

Compartmentation of cardiac adenine nucleotides and formation of adenosine.

J Schrader, E Gerlach.   

Abstract

After prelabeling the adenine nucleotides (ATP, ADP, AMP) of isolated perfused guinea pig hearts with either 14C-adenine or 14C-adenosine for 35 min, labeled adenosine, inosine, hypoxanthine and cyclic 3'5'-AMP (cAMP) were continuously released into the cardiac perfusate. Determination of the specific activities (SA) of the adenine nucleotides, cAMP, and their breakdown products (adenosine, inosine, hypoxanthine) in tissue and perfusate revealed: Under steady state conditions the SA of adenosine and cAMP in the perfusate were of the same order of magnitude and proved to be many times higher than the SA of the respective precursor adenine nucleotides. This difference was observed regardless whether adenine or adenosine was used as prelabeling substances. The SA of inosine and hypoxanthine in the perfusate were constantly lower than the SA of adenosine. Cardiac ischemia of 6 min, which resulted in a markedly increased formation of adenosine, led to a pronounced decrease in the SA of adenosine released from the heart. Our findings provide evidence that at least two different adenine nucleotide compartments of the heart severe as precursors for the formation of adenosine and cAMP, one characterized by a high, the other by a lower SA. Under normoxic conditions adenosine and cAMP released into the cardiac perfusate are derived mainly from a nucleotide fraction of high SA, which appears to be rather small. During ischemia a second compartment of much lower SA in addition contributes to the formation of adenosine.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 189285     DOI: 10.1007/bf00585148

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  23 in total

1.  Differential spectrophotometry of purine compounds by means of specific enzymes; determination of adenine compounds.

Authors:  H M KALCKAR
Journal:  J Biol Chem       Date:  1947-02       Impact factor: 5.157

2.  ON THE CALCULATION OF "TURNOVER TIME" AND "TURNOVER RATE" FROM EXPERIMENTS INVOLVING THE USE OF LABELING AGENTS.

Authors:  D B Zilversmit; C Entenman; M C Fishler
Journal:  J Gen Physiol       Date:  1943-01-20       Impact factor: 4.086

3.  A radioisotopic method for measuring the formation of adenosine 3',5'-cyclic monophosphate in incubated slices of brain.

Authors:  H Shimizu; J W Daly; C R Creveling
Journal:  J Neurochem       Date:  1969-12       Impact factor: 5.372

4.  Sites of adenosine production in cardiac and skeletal muscle.

Authors:  R Rubio; R M Berne; J G Dobson
Journal:  Am J Physiol       Date:  1973-10

5.  [Comparative studies on the formation of adenosine in the myocardium of different animal species in oxygen deficiency].

Authors:  E Gerlach; B Deuticke
Journal:  Klin Wochenschr       Date:  1966-11-15

6.  Release of adenosine by the normal myocardium in dogs and its relationship to the regulation of coronary resistance.

Authors:  R Rubio; R M Berne
Journal:  Circ Res       Date:  1969-10       Impact factor: 17.367

7.  Changes in content of purine nucleoside in canine myocardium during coronary occlusion.

Authors:  R A Olsson
Journal:  Circ Res       Date:  1970-03       Impact factor: 17.367

8.  Functional compartmentation of ATP and creatine phosphate in heart muscle.

Authors:  S Gudbjarnason; P Mathes; K G Ravens
Journal:  J Mol Cell Cardiol       Date:  1970-09       Impact factor: 5.000

9.  Separation and purification of cyclic nucleotides by ion-exchange resin column chromatography.

Authors:  G Schultz; E Böhme; J G Hardman
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

10.  Influence of dipyridamol (Persantin) on myocardial adenosine metabolism.

Authors:  W Kübler; P G Spieckermann; H J Bretschneider
Journal:  J Mol Cell Cardiol       Date:  1970-03       Impact factor: 5.000

View more
  30 in total

1.  Atrial bioenergetic variations in moderate hypoxia: danger or protective defense?

Authors:  L Caparrotta; R Poja; E Ragazzi; G Froldi; L Pandolfo; M Prosdocimi; G Fassina
Journal:  Basic Res Cardiol       Date:  1989 Sep-Oct       Impact factor: 17.165

2.  Adenosine-induced release of cyclic adenosine 3',5'-monophosphate from the left ventricle in the anaesthetized intact dog.

Authors:  T Huynh-Thu; J Lammerant
Journal:  J Physiol       Date:  1978-06       Impact factor: 5.182

3.  Adenosine as inhibitor of myocardial effects of catecholamines.

Authors:  J Schrader; G Baumann; E Gerlach
Journal:  Pflugers Arch       Date:  1977-11-25       Impact factor: 3.657

Review 4.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

5.  Myocardial ischaemia and cardiac pain - a mysterious relationship.

Authors:  Austin Leach; Mike Fisher
Journal:  Br J Pain       Date:  2013-02

6.  The role of histamine in cardiac anaphylaxis; characterization of histaminergic H1- and H2-receptor effects.

Authors:  S B Felix; G Baumann; S Helmus; U Sattelberger
Journal:  Basic Res Cardiol       Date:  1988 Sep-Oct       Impact factor: 17.165

7.  Adenosine receptors in frog sinus venosus: slow inhibitory potentials produced by adenine compounds and acetylcholine.

Authors:  H C Hartzell
Journal:  J Physiol       Date:  1979-08       Impact factor: 5.182

8.  A comparison of adenine and some derivatives on pig isolated tracheal muscle.

Authors:  Y Bach-Dieterle; W E Holden; A F Junod
Journal:  Br J Pharmacol       Date:  1983-12       Impact factor: 8.739

9.  Differential presynaptic modulation of noradrenaline release in human atrial tissue in normoxia and anoxia.

Authors:  G Münch; T Kurz; T Urlbauer; M Seyfarth; G Richardt
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

10.  Free creatine available to the creatine phosphate energy shuttle in isolated rat atria.

Authors:  F Savabi
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.